195 related articles for article (PubMed ID: 36521246)
21. Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies.
Waissi W; Paix A; Nicol A; Noël G; Burckel H
Crit Rev Oncol Hematol; 2020 Sep; 153():103060. PubMed ID: 32707435
[TBL] [Abstract][Full Text] [Related]
22. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.
Deng S; Vlatkovic T; Li M; Zhan T; Veldwijk MR; Herskind C
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230796
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced signaling pathways that promote cancer cell survival (review).
Hein AL; Ouellette MM; Yan Y
Int J Oncol; 2014 Nov; 45(5):1813-9. PubMed ID: 25174607
[TBL] [Abstract][Full Text] [Related]
24. Emerging targets for radioprotection and radiosensitization in radiotherapy.
Kumar S; Singh RK; Meena R
Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
[TBL] [Abstract][Full Text] [Related]
25. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
26. Torin2 Suppresses Ionizing Radiation-Induced DNA Damage Repair.
Udayakumar D; Pandita RK; Horikoshi N; Liu Y; Liu Q; Wong KK; Hunt CR; Gray NS; Minna JD; Pandita TK; Westover KD
Radiat Res; 2016 May; 185(5):527-38. PubMed ID: 27135971
[TBL] [Abstract][Full Text] [Related]
27. FK228 sensitizes radioresistant small cell lung cancer cells to radiation.
Li H; Ma L; Bian X; Lv Y; Lin W
Clin Epigenetics; 2021 Feb; 13(1):41. PubMed ID: 33632300
[TBL] [Abstract][Full Text] [Related]
28. Signal transduction inhibitors as radiosensitizers.
Tenzer A; Zingg D; Riesterer O; Vuong V; Bodis S; Pruschy M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):727-42. PubMed ID: 12678723
[TBL] [Abstract][Full Text] [Related]
29. Nucleoside analogs as a radiosensitizer modulating DNA repair, cell cycle checkpoints, and apoptosis.
Yasui H; Iizuka D; Hiraoka W; Kuwabara M; Matsuda A; Inanami O
Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):439-452. PubMed ID: 31560250
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.
Dragojevic S; Ji J; Singh PK; Connors MA; Mutter RW; Lester SC; Talele SM; Zhang W; Carlson BL; Remmes NB; Park SS; Elmquist WF; Krishnan S; Tryggestad EJ; Sarkaria JN
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):e54-e62. PubMed ID: 34400266
[TBL] [Abstract][Full Text] [Related]
31. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
32. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
[TBL] [Abstract][Full Text] [Related]
33. The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage.
Zaidi S; McLaughlin M; Bhide SA; Eccles SA; Workman P; Nutting CM; Huddart RA; Harrington KJ
PLoS One; 2012; 7(4):e35436. PubMed ID: 22523597
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of radiosensitization by the Chk1/2 inhibitor AZD7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair.
Morgan MA; Parsels LA; Zhao L; Parsels JD; Davis MA; Hassan MC; Arumugarajah S; Hylander-Gans L; Morosini D; Simeone DM; Canman CE; Normolle DP; Zabludoff SD; Maybaum J; Lawrence TS
Cancer Res; 2010 Jun; 70(12):4972-81. PubMed ID: 20501833
[TBL] [Abstract][Full Text] [Related]
35. Flavonoids sensitize tumor cells to radiation: molecular mechanisms and relevance to cancer radiotherapy.
Tiwari P; Mishra KP
Int J Radiat Biol; 2020 Mar; 96(3):360-369. PubMed ID: 31738629
[No Abstract] [Full Text] [Related]
36. BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
Kong Y; Xu C; Sun X; Sun H; Zhao X; He N; Ji K; Wang Q; Du L; Wang J; Zhang M; Liu Y; Wang Y; Liu Q
Cancer Biol Med; 2021 Dec; 19(8):1150-71. PubMed ID: 34846107
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin-modification of DNA repair and ionizing radiation lethality in yeast, Saccharomyces cerevisiae.
Dolling JA; Boreham DR; Brown DL; Raaphorst GP; Mitchel RE
Mutat Res; 1999 Mar; 433(2):127-36. PubMed ID: 10102039
[TBL] [Abstract][Full Text] [Related]
38. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes.
Kery M; Papandreou I
Br J Radiol; 2020 Nov; 93(1115):20200067. PubMed ID: 32462882
[TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials].
Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A
Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141
[TBL] [Abstract][Full Text] [Related]
40. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy.
Prevo R; Fokas E; Reaper PM; Charlton PA; Pollard JR; McKenna WG; Muschel RJ; Brunner TB
Cancer Biol Ther; 2012 Sep; 13(11):1072-81. PubMed ID: 22825331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
